"Modernste Medizin - mit Sicherheit Das Universitätsklinikum Erlangen bietet seit seiner Gründung im Jahr 1815 Medizin auf höchstem Niveau. In Diagnose und Therapie werden neueste Erkenntnisse der medizinischen Forschung sowie modernste Geräte eingesetzt. Uni-Klinikum, Universität und Stadt verfolgen gemeinsam das Ziel, "Stadt der Gesundheit und Medizin" zu werden. Im nordbayerischen Medizincluster "Medical Valley" engagieren sie sich gemeinsam mit weiteren Partnern aus Wissenschaft, Wirtschaft und Politik für die internationale Führungsrolle der Region auf dem Gebiet der Hightech-Medizin."

During the past decade, Department of Gynecology and Obstetrics, Erlangen University Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Gynecology and Obstetrics, Erlangen University Hospital" #1 sponsor was "Institut fuer Frauengesundheit" with 5 trials, followed by "University of Erlangen-Nürnberg Medical School" with 3 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Hofmann, Bernd, M.D." with 1 trials sponsored and "InflaRx GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Gynecology and Obstetrics, Erlangen University Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Eisai GmbH" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Department of Gynecology and Obstetrics, Erlangen University Hospital" are "Breast Cancer" (3 trials), "Breast Cancer Female" (3 trials), "Breast Neoplasms" (2 trials), "Malignant Neoplasm of Breast" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Department of Gynecology and Obstetrics, Erlangen University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Gynecology and Obstetrics, Erlangen University Hospital" are "Drug" (9 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALLEVYN Gentle border" (1 trials), "Chemotherapy" (1 trials), "Cyclophosphamide" (1 trials), "Epirubicin" (1 trials) and "Eribulin Injection [Halaven]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Gynecology and Obstetrics, Erlangen University Hospital" are 8 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Gynecology and Obstetrics, Erlangen University Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Gynecology and Obstetrics, Erlangen University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Gynecology and Obstetrics, Erlangen University Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".